Legal News 20 February 2026 - 27 February 2026

JPMorgan Chase Faces Fresh Legal Pressure as Employee Drug-Cost Suit Moves Ahead
···

JPMorgan Chase Faces Fresh Legal Pressure as Employee Drug-Cost Suit Moves Ahead

A federal judge in Manhattan allowed JPMorgan Chase employees to pursue key claims in a proposed class action alleging the bank mismanaged its health and prescription benefits plan, leading to inflated drug and premium costs. The suit claims the plan paid markups averaging 211% on 366 generic drugs through CVS Caremark. JPMorgan declined to comment. The judge dismissed some fiduciary-duty claims but let prohibited-transaction claims proceed.
March 10, 2026
Navan (NAVN) stock slips in premarket as lawsuit overhang bites after Thursday rally
···

Navan (NAVN) stock slips in premarket as lawsuit overhang bites after Thursday rally

Navan shares dropped 2.7% to $10.30 in premarket trading Friday, reversing part of a 14% surge from the prior session. The company will report fourth-quarter and full-year results after markets close on March 25. Investors are watching a securities class action filed Feb. 23 over Navan’s October IPO, with an April 24 lead-plaintiff deadline. Greenoaks Capital Partners disclosed a 6.9% stake in the company.
February 27, 2026
Oracle stock price today: ORCL ticks up after hours as April 6 lawsuit deadline nears
···

Oracle stock price today: ORCL ticks up after hours as April 6 lawsuit deadline nears

Oracle shares rose 0.3% to $156.54 in after-hours trading Thursday, with about 14.9 million shares changing hands. A shareholder lawsuit filed Feb. 3 in Delaware accuses Oracle and top executives of misleading investors about how quickly AI-related spending would drive growth. Investors face an April 6 deadline to seek lead-plaintiff status in the case. Oracle recently said it aims to raise up to $50 billion in 2026 through debt and share sales.
February 20, 2026